NCT03798626 2026-01-27Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal CancersNovartisPhase 1 Completed167 enrolled
NCT06839105 2025-05-31A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced MalignanciesShanghai Junshi Bioscience Co., Ltd.Phase 1 Recruiting214 enrolled